CHAO CHENG to E2F4 Transcription Factor
This is a "connection" page, showing publications CHAO CHENG has written about E2F4 Transcription Factor.
Connection Strength
2.105
-
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients. BMC Cancer. 2017 05 02; 17(1):306.
Score: 0.578
-
Integrative Genomic Analyses Yield Cell-Cycle Regulatory Programs with Prognostic Value. Mol Cancer Res. 2016 Apr; 14(4):332-43.
Score: 0.531
-
E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder Cancer. Mol Cancer Res. 2015 Sep; 13(9):1316-24.
Score: 0.506
-
E2F4 regulatory program predicts patient survival prognosis in breast cancer. Breast Cancer Res. 2014 Dec 02; 16(6):486.
Score: 0.489